Delivery Order SPE2DB22D9143-SPE2DB24FZB87

Award Date 4/23/24
Potential Completion Date 5/14/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, with a ceiling value of $1,407.16 and an ultimate completion date of September 12, 2023. The contract type is firm fixed price. This award is part of a larger indefinite delivery contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $4,974.46 and a period of performance through May 10, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, at a ceiling value of $4,974.44. The contract has a firm fixed price pricing type and an ultimate completion date of June 6, 2024. This award is associated with a larger indefinite delivery contract (IDC) between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the delivery of EXPAREL 133MG/10ML 10S, a pharmaceutical product, with a firm fixed price ceiling value of $4,283.46 and a period of performance through April 30, 2024. The award is not associated with any set-aside program. DMS Pharmaceutical Group holds a significant indefinite delivery...
This is a $1,427.82 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the pharmaceutical product EXPAREL 133 MG/10 ML VIAL 10ML and has a completion date of June 12, 2024. The award is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which allows the DLA to place delivery orders for a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $17,133.84, is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML. The contract is a firm fixed-price delivery order with a completion date of May 24, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, under a firm fixed-price contract. The award has a ceiling value of $1,507.22 and an ultimate completion date of January 27, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,974.44, is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs...
This is a $24,872.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML and has a completion date of May 23, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,283.46 firm fixed-price contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, with a completion date of July 24, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
  • SPE2DB22D9143
    Indefinite Delivery Contract
  • SPE2DB22D9143-SPE2DB24FZB87
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product EXPAREL 133 MG/10 ML VIAL 10ML, with a ceiling value of $4,582.72 and a performance period ending on May 14, 2024.

The award is issued under a larger indefinite delivery contract (IDC) vehicle with DMS Pharmaceutical Group, valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. This IDC, under the SPE2DB program, complements the company's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) sites. Through this vehicle, DMS Pharmaceutical Group provides a wide array of medications, including both common and specialized pharmaceutical products, to the DoD healthcare system.

Generated 7/23/24, 11:09 AM